NORTH HOUSTON SURGICAL HOSPITAL — History
CCN 670280 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$60M
Latest Revenue (FY2022)
+157.7%
Revenue CAGR (3yr)
3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $9M | $35M | $60M | +69.3% | +157.7% |
| Operating Expenses | $8M | $35M | $58M | +66.0% | +168.0% |
| Operating Margin | 10.6% | 1.4% | 3.3% | +138.6% | -43.9% |
| Net Income | $1M | $0M | $2M | +304.1% | +44.4% |
| Licensed Beds | 12 | 56 | 56 | +0.0% | +116.0% |
| Total Patient Days | 144 | 438 | 1,471 | +235.8% | +219.6% |
| Medicare Day % | 15% | 16% | 17% | +12.1% | +6.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +564.2% ($9M → $60M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+157.7%
This Hospital
+7.6%
State Avg
Latest Margin
3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $86M | -0.3% |
| FY2024 (proj) | $111M | -3.9% |
| FY2025 (proj) | $137M | -7.6% |